Siemens Receives FDA Approval for the VERSANT 440 Molecular System
Siemens Offers Next Generation Molecular Viral Load Testing to the U.S. Market DEERFIELD, Ill., Feb. 18 /PRNewswire/ -- Siemens Healthcare (http://www.siemens.com/diagnostics ) announced today that its VERSANT(TM) 440 Molecular System has been approved for mark...Lutonix, Inc. Announces First Patient Enrollments in Three Separate Clinical Trials
...ture-backed medical device start-up based in Minneapolis, MN. Current investors include: Delphi Ventures, Rivervest Ventures, US Venture Partners, and versant Ventures. ...Novasys Medical Receives $18.95 Million in Second Tranche of Series D Financing
...ved the first tranche of the Series D round in May 2008, with lead investor versant Ventures and new investors ThreeArch Partners and Skyline Ventures. All thr...n covering Renessa soon." Beckie Robertson, Managing Director with versant Ventures, said, "We're really pleased with the reimbursement progress Novas...I-Therapeutix, Inc. Closes $15 Million Financing
... million dollar Series C financing. The round was led by Polaris Venture Partners in Waltham, MA, with continued participation by existing investors, versant Ventures and SV Life Sciences. The proceeds will be used to commercialize I-ZIP(R) Ocular Bandage in the United States and to develop sustained...Cadence Pharmaceuticals Completes $86.6 Million Private Placement of Common Stock
... on the day of pricing, February 13, 2009. The financing was led by Venrock with participation by Frazier Healthcare Ventures, Domain Associates, versant Ventures, New Enterprise Associates, Bay City Capital and T. Rowe Price Associates. The securities sold in this private placement have not been r...Cadence Pharmaceuticals to Raise $86.6 Million in a Private Placement of Common Stock
...is expected to close on February 18, 2009. The financing was led by Venrock with participation by Frazier Healthcare Ventures, Domain Associates, versant Ventures, New Enterprise Associates, Bay City Capital and T. Rowe Price Associates. The securities to be sold in this private placement have not ...The Foundry Announces New Partners and Completion of Series A Financing for Eleventh Company
... where he served as President and CEO. Mr. Engelson previously served as the Chief Financial Officer of Fluidigm Corporation, as a Venture Partner at versant Ventures and as an Entrepreneur-in-Residence at Institutional Venture Partners. Previously, Mr. Engelson spent 13 years in various operating roles at...Acclarent, Inc. Closes $26 Million Financing
...ies. Johnson & Johnson Development Corporation (JJDC) joined existing prominent investors New Enterprise Associates, Inc., Delphi Ventures, versant Ventures, and Meritech Capital Partners in this financing. "The addition of JJDC together with the support of our existing financial partners w...Transcend Medical Announces New President and CEO and Appointment of Chairman of the Board
...Inc. ForSight Labs is backed by investors Morgenthaler Ventures ( http://www.morgenthaler.com ), Split Rock Partners ( http://www.splitrock.com ), and versant Ventures ( http://www.versantventures.com ). ...Lutonix Inc. Announces $20 Million Series B Financing
... versant Ventures Leads Investment in Lutonix to Fund Human...tial human clinical trials. The round was led by versant Ventures ( http://www.versantventures.com ), a lea...financing, Kevin Wasserstein, Managing Director of versant Ventures, and John Maroney, Managing Director of D...VERSANT HIV RNA 3.0 Assay (bDNA)
Description:... The versant HIV-1 RNA Assay (bDNA) delivers unmatched precision and reproducibility, so... the variability seen with other assays. If you need more reasons to choose versant HIV bDNA, consider this: it's the only viral load assay specifically design...ForteBio, Inc. Closes $25 Million In Series C Financing
...o participated as a new investor in this financing round, as did existing investors Alloy Ventures, Latterell Venture Partners, The Vertical Group and versant Ventures. "With this new financing, ForteBio is well-positioned to continue to introduce industry-leading products and expand our market globally," ...Pathwork Diagnostics Closes $20M Financing
...th joins the existing investors participating in this round, including Prospect Venture Partners, Advent Venture Partners, Novus Ventures, Venrock and versant Ventures. "Completing this successful financing in the current economy, with well-respected investment firms is a strong vote of confidence in our tec...Cadence Pharmaceuticals Completes $49.3 Million Registered Direct Offering
...ated in the first half of 2009." In addition to significant participation from existing investors Domain Associates, Frazier Healthcare Ventures and versant Ventures, as well as from certain executive officers and directors of Cadence, other investors participating in this financing included, among others,...XTL Biopharmaceuticals Ltd. Announces $9.6 Million Private Placement to Institutional Investors
...ican Depositary Receipts (ADRs). The lead investors in the transaction are Perceptive Life Sciences Fund, Quogue Capital LLC, SCO Capital Partners and versant Capital. Ron Bentsur, Chief Executive Officer of XTL, commented, "We are very pleased to have consummated this financing with high-quality investors ...OpGen Announces $23.6 Million Series A Financing
...HL Medical Partners, Highland Capital Partners and versant Ventures Lead Round to Help Transform ...ighland's web site at http://www.hcp.com . About versant Ventures versant Ventures ( http://www.versantventures.com ) is a l...